Overcoming Challenges with a Patient-Centered Approach in the Management of HIV: Emerging Treatment Strategies for Improving Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2019 Spring Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from July 1, 2019 to August 1, 2020

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by educational grants from
Viiv Healthcare and Merck Sharp & Dohme Corp.

The human immunodeficiency virus (HIV) is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. HIV infects vital cells in the human immune system such as helper T cells, macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of specific mechanisms. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections. The CDC estimates that 1,218,400 persons in the United States aged 13 years and older are living with HIV infection. Additionally, an estimated 6,955 people died from HIV and AIDS in 2017. Fortunately for patients with HIV, several new therapies have become available over the past few years, and more are set to become available in the next year. With so many new options entering the treatment paradigm, it is critical that medical directors, practicing physicians, nurses and other healthcare professionals are updated on these emerging options and guidelines and strategies for implementing them into the treatment paradigm and individualizing therapy, which will ultimately improve patient outcomes.

Upon completion of this activity, participants will be able to:

  • Analyze the clinical and economic impact of an HIV infection on a patient

  • Compare and contrast current and emerging HIV antiretroviral agents based on clinical safety and efficacy, barrier to resistance, and recommendations for use

  • Explore the emerging role of NNRT inhibitors in the management of HIV and how these agents should be integrated into the treatment paradigm

  • Discuss clinical data on emerging HIV-treatment paradigms, including novel medication combinations and drug-delivery or dosing methods to simplify ART regimens

  • Identify patients with HIV who may benefit from switching ART

  • Assess current and evolving strategies used by managed care organizations (MCOs) to facilitate high quality care for members with HIV

Faculty: Ian Frank, MD
Professor of Medicine
Associate Chief, Infectious Diseases Division
Director, Clinical-Therapeutics Program
Penn Center for AIDS Research, University of Pennsylvania


Dr. Frank serves on an advisory board for Gilead Sciences and ViiV Healthcare. He has received grant/research support from Janssen. His presentation has been reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by educational granta from
Viiv Healthcare and Merck Sharp & Dohme Corp.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue